恒瑞医药(01276)10月28日斥资7576.9万元回购118.6万股A股

Core Viewpoint - Heng Rui Medicine (01276) announced a share buyback plan, intending to repurchase 1.186 million A-shares for a total expenditure of 75.769 million yuan by October 28, 2025 [1] Company Summary - The company plans to spend 75.769 million yuan on the buyback [1] - The total number of shares to be repurchased is 1.186 million [1]